These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14666315)

  • 1. [Potential of Bacillus thuringiensis israelensis Berliner for controlling Aedes aegypti].
    Polanczyk RA; Garcia Mde O; Alves SB
    Rev Saude Publica; 2003 Dec; 37(6):813-6. PubMed ID: 14666315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray application of Bacillus thuringiensis israelensis (Bti strain AM65-52) against Aedes aegypti (L.) and Ae. albopictus Skuse populations and impact on dengue transmission in a dengue endemic residential site in Malaysia.
    Tan AW; Loke SR; Benjamin S; Lee HL; Chooi KH; Sofian-Azirun M
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):296-310. PubMed ID: 23082582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Larvicide, Bacillus thuringiensis israelensis Strain AM 65-52 Water Dispersible Granule Formulation Impacts Both Dengue Vector, Aedes aegypti (L.) Population Density and Disease Transmission in Cambodia.
    Setha T; Chantha N; Benjamin S; Socheat D
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004973. PubMed ID: 27627758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the gene profile of Bacillus thuringiensis Berliner isolated from Brazilian ecosystems and showing pathogenic activity against mosquito larvae of medical importance.
    Soares-da-Silva J; Queirós SG; de Aguiar JS; Viana JL; Neta MDRAV; da Silva MC; Pinheiro VCS; Polanczyk RA; Carvalho-Zilse GA; Tadei WP
    Acta Trop; 2017 Dec; 176():197-205. PubMed ID: 28823909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of larviciding with a Bacillus thuringiensis israelensis formulation, VectoBac WG, on dengue mosquito vectors in a dengue endemic site in Selangor State, Malaysia.
    Lee HL; Chen CD; Masri SM; Chiang YF; Chooi KH; Benjamin S
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):601-9. PubMed ID: 19058596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of Aedes aegypti (L.) strains from Havana to a Bacillus thuringiensis var. israelensis].
    Menéndez Díaz Z; Rodríguez Rodríguez J; Gato Armas R; Companioni Ibañez A; Díaz Pérez M; Bruzón Aguila RY
    Rev Cubana Med Trop; 2012; 64(3):324-9. PubMed ID: 23424808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus thuringiensis var. israelensis misting for control of Aedes in cryptic ground containers in north Queensland, Australia.
    Jacups SP; Rapley LP; Johnson PH; Benjamin S; Ritchie SA
    Am J Trop Med Hyg; 2013 Mar; 88(3):490-6. PubMed ID: 23358637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Bacillus thuringiensis israelensis in integrated vector control of Aedes sp. in Sri Lanka: a prospective controlled effectiveness study.
    Tissera HA; Samaraweera PC; Jayamanne BDW; Janaki MDS; U Chulasiri MPP; Rodrigo C; Fernando SD
    Trop Med Int Health; 2018 Feb; 23(2):229-235. PubMed ID: 29164802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
    Mittal PK; Adak T; Batra CP
    J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the efficacy of a combination of Mesocyclops aspericornis and Bacillus thuringiensis var. israelensis by community-based products in controlling Aedes aegypti larvae in Thailand.
    Kosiyachinda P; Bhumiratana A; Kittayapong P
    Am J Trop Med Hyg; 2003 Aug; 69(2):206-12. PubMed ID: 13677377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal application of Bacillus thuringiensis serovar israelensis for dengue vector control.
    Seleena P; Lee HL; Chiang YF
    J Vector Ecol; 2001 Jun; 26(1):110-3. PubMed ID: 11469179
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the present dengue situation and control strategies against Aedes aegypti in Cebu City, Philippines.
    Mahilum MM; Ludwig M; Madon MB; Becker N
    J Vector Ecol; 2005 Dec; 30(2):277-83. PubMed ID: 16599163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus thuringiensis israelensis (Bti) for the control of dengue vectors: systematic literature review.
    Boyce R; Lenhart A; Kroeger A; Velayudhan R; Roberts B; Horstick O
    Trop Med Int Health; 2013 May; 18(5):564-77. PubMed ID: 23527785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosquitocidal potential of silver nanoparticles synthesized using local isolates of Bacillus thuringiensis subsp. israelensis and their synergistic effect with a commercial strain of B. thuringiensis subsp. israelensis.
    Thammasittirong A; Prigyai K; Thammasittirong SN
    Acta Trop; 2017 Dec; 176():91-97. PubMed ID: 28754251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of Bacillus thuringiensis israelensis (AM65-52) treatment for the control of Aedes aegypti using vehicle-mounted WALS® application in a densely populated urban area of Puerto Rico.
    Harris AF; Sanchez Prats J; Nazario Maldonado N; Piovanetti Fiol C; García Pérez M; Ramírez-Vera P; Miranda-Bermúdez J; Ortiz M; DeChant P
    Pest Manag Sci; 2021 Apr; 77(4):1981-1989. PubMed ID: 33314578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic architecture of a complex trait: Resistance to multiple toxins produced by Bacillus thuringiensis israelensis in the dengue and yellow fever vector, the mosquito Aedes aegypti.
    Bonin A; Paris M; Frérot H; Bianco E; Tetreau G; Després L
    Infect Genet Evol; 2015 Oct; 35():204-13. PubMed ID: 26238211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of entomopathogenic bacteria against Aedes polynesiensis, the vector of lymphatic filariasis in French Polynesia.
    Mercer DR; Nicolas L; Thiery I
    J Am Mosq Control Assoc; 1995 Dec; 11(4):485-8. PubMed ID: 8825516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitness costs of resistance to Bti toxins in the dengue vector Aedes aegypti.
    Paris M; David JP; Despres L
    Ecotoxicology; 2011 Aug; 20(6):1184-94. PubMed ID: 21461926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Bacillus thuringiensis israelensis tablet formulation, vectobac DT, for control of dengue mosquito vectors in potable water containers.
    Benjamin S; Rath A; Fook CY; Lim LH
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):879-92. PubMed ID: 16295540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue vector control: present status and future prospects.
    Yap HH; Chong NL; Foo AE; Lee CY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Dec; 10 Suppl():S102-8. PubMed ID: 7844836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.